NEM heads into its July 23 earnings release with analysts broadly bullish but marking down targets — a divergence between conviction on the story and caution on near-term execution.
The Street's direction of travel is clear: target prices are moving lower, even as ratings hold. In the past week alone, Scotiabank maintained its Sector Outperform but clipped its target from $151 to $147. TD Cowen went further, upgrading the stock to Buy while simultaneously cutting its target from $129 to $127 — a rare combination that captures the mood precisely: analysts like the risk/reward at current levels but see less room for multiple expansion than they did a month ago. B of A Securities held its Buy rating but trimmed from $157 to $132, the sharpest target reduction in the recent cycle. The consensus mean price target now rests at $133.47, implying roughly 41% upside to Tuesday's close of $94.75 — a gap that is either an opportunity or a warning about where consensus was anchored too high. All analyst data is current as of this week.
Positioning in the lending market gives shorts no particular edge here. Availability is essentially unlimited — borrowing shares is trivially easy, with shares available to lend dwarfing short demand by orders of magnitude. Short interest is correspondingly low at 1.76% of free float, down about 0.7% on the week and effectively rangebound for the past six weeks. Cost to borrow has eased to 0.43%, down roughly 24% from a week ago. None of this tells a squeeze story, nor does it flag a building short thesis. The lending market is simply not the source of tension in NEM right now.
Options positioning has drifted more bullish than usual. The put/call ratio has fallen to 0.62 — below its 20-day average of 0.66 and near the 52-week low of 0.60 — a signal that options traders are buying calls rather than hedging with puts. That's a mild but consistent lean toward the upside into the print. The z-score of -0.92 is not extreme, so this isn't a crowded directional bet, more a quiet tilt toward optimism.
The fundamental case heading into Q2 has two distinct poles. Bulls point to 5.3 million ounces of projected 2026 production, a strengthened cost structure after the Newcrest acquisition and the divestiture of six higher-cost mines, and gold prices widely expected to test $4,000 per ounce in the second half. Quality metrics back the bull case: the ORTEX factor scores show an EPS surprise rank in the 84th percentile and a dividend score in the 90th — both well above sector norms. Bears counter with the recent underperformance: NEM is down 5.5% over the past month to $94.75, lagging close peers like AEM (down 3.9% on the week) and ABX (down 2.0%), though none of the gold complex has had a strong week. The bear case also flags integration risk from two large acquisitions and a downside scenario pegged as low as $41 per share on a $2,500 gold price assumption — a reminder of how leveraged this stock remains to the commodity.
Insider activity adds a minor cautionary note. The CEO, CFO-equivalent, and several EVPs have all sold shares in recent months — most recently an EVP sale of 3,000 shares at $92.38 on July 1 — though the significance scores on these trades are low, and the pattern looks more like routine scheduled selling than a directional signal. Net insider sales over 90 days run to roughly $4.4 million across multiple executives, none of it individually alarming but collectively consistent with a management team that has been trimming into strength rather than adding.
The earnings history adds nuance worth watching. The most recent print on May 12 delivered a -1.4% day-one move followed by a -12.9% five-day drawdown, while the April 23 result moved the stock up 7.9% on the day before fading 0.7% over five days. The pattern is mixed enough that the direction of the immediate reaction has been less predictive than the subsequent drift — the setup into July 23 is therefore less about whether NEM beats on ounces and more about whether management's commentary on costs, capital returns, and gold price realisation resets the Street's target-cutting cycle or reverses it.
See the live data behind this article on ORTEX.
Open NEM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
